Specifically, one recoding site located in AZIN1 has previously shown to be differentially edited between hepatocellular carcinoma [18], non-small-cell lung cancers [19], esophageal squamous cell carcinoma [20], and colorectal cancer [21,22,23], and their respective normal tissues. This evidence concerns the gene AZIN1 and hepatocellular carcinoma.